Unlike CT, MRI provided exquisite anatomic detail, with clear differentiation of tissues such as GM, WM, and CSF. Subcortical structures were also clearly visible, such as caudate, putamen, globus pallidus, thalamus, and hippocampus. Visualization of cerebral sulci permitted the delineation of lobes and Brodmann areas. Because MRI did not entail any exposure to ionizing radiation (unlike CT), new research
options Inhibitors,research,lifescience,medical were available, such as the study of children or the use of repeated scans to track brain development or brain aging. MRI studies of schizophrenia quickly provided evidence to support the primacy of the neurodevelopmental hypothesis. The first quantitative case-control MRI study of schizophrenia appeared in 1986.9 It used the superior anatomic resolution of MR to measure frontal lobe Inhibitors,research,lifescience,medical size in addition to cerebral and cranial size; it found that all of these structures were significantly smaller in patients than in controls, and that these decreases were related to negative symptoms and cognitive impairment. Because cranial expansion occurs secondary to cerebral growth, the study suggested that patients with schizophrenia may have some type of early developmental abnormality. …the present findings suggest that patients suffering from schizophrenia may have had some type of early developmental abnormality that Inhibitors,research,lifescience,medical led to impaired capacity of the brain to grow, thereby causing
a correspondingly small cranial area. This could, of course, be due to a variety of factors, Inhibitors,research,lifescience,medical such as genetics, maternal nutrition, maternal alcohol consumption, difficulties during delivery, or environmental factors (eg, nutrition and http://www.selleckchem.com/products/nlg919.html infections) during the first year of life. (p 142-143) The findings were not consistent with an atrophic process, through which brain tissue was lost over time. The findings of decreased frontal, cerebral, and cranial size were subsequently repeatedly confirmed, as were the relevance of the various potential causes of early neurodevelopmental abnormalities.10-22 At the same time (and
in the same issue of Archives of Inhibitors,research,lifescience,medical General Psychiatry) new neuropathology data also emerged that provided indirect support for the neurodevelopmental hypothesis. why Benes et al conducted quantitative analyses of glial density, neuron-glia ratios, and neuronal size in the prefrontal, anterior cingulate, and primary motor cortex.23 Their findings did not meet neuropathological criteria for evidence of a neurodegenerative/atrophic process: neuronal loss, gliosis, a decrease in the neuron:glia ratio, and neuronal shrinkage. Instead they observed reduced numbers of neurons per unit volume of tissue and a decrease in glia. They concluded that their findings did not support the presence of a neurodegenerative process in schizophrenia. These findings have also been repeatedly confirmed.24-27 There is now a consensus that the neuropathology of schizophrenia is defined by increased neuronal density, a reduction in the dendritic arbor, and cortical thinning.